Mechanisms of neurotoxicity and neuroprotection in 6-OHDA models of Parkinson's disease

Mechanisms of neurotoxicity and neuroprotection in 6-OHDA models of Parkinson's disease

Bibliographic Details
Main Author:	Hanrott, Katharine Elizabeth
Published:	University of Bath 2006
Subjects:	616.83307
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.432363

Similar Items

The neuropsychological consequences of Parkinson's disease and accompanying neurosurgical procedures
by: Webber, Helen
Published: (2005)

Conditional proteasome gene deletion : molecular neuropathology and the pathogenesis of Parkinson’s disease
by: Paine, Simon Marcus Liddell
Published: (2012)

A comparison of three depression scales as screening tools for depression in Parkinson's disease
by: Baillon, Sarah Frances
Published: (2013)

Oscillations in the basal ganglia in Parkinson's disease patients and their influence on the cerebral cortex and behavioural performance
by: Fogelson, Noa
Published: (2005)

The functional significance of oscillatory local field potential activity in the Parkinsonian subthalamic nucleus
by: Williams, David
Published: (2004)

Pathological changes in mesostriatal neurons in a PKC-gamma mutant rat
by: Al-kushi, Abdullah G.
Published: (2008)

The role of the subthalamic nucleus in network-driven synchronous oscillation in the basal ganglia
by: Wilson, Claire Louise
Published: (2004)

Neuroprotective effect and mechanism of baicalin on Parkinson’s disease model induced by 6-OHDA
by: Tu L, et al.
Published: (2020-01-01)

Tetrahydroxystilbene Glucoside Produces Neuroprotection against 6-OHDA-Induced Dopamine Neurotoxicity
by: Chun Huang, et al.
Published: (2018-01-01)

Neuroprotective effect of Glyceryl nonivamide on 6-OHDA- or H2O2- induced neurotoxicity
by: Yi-Ching Lin, et al.
Published: (2007)

Neuroprotective Effect of 1,4-Naphthoquinones in an <i>In Vitro</i> Model of Paraquat and 6-OHDA-Induced Neurotoxicity
by: Ekaterina Menchinskaya, et al.
Published: (2021-09-01)

Nicotinamide : neuroprotection and neurodegeneration mechanisms in Parkinson's disease
by: Cartwright, Lindsay Sarah
Published: (2005)

Neuroprotective Effects on Dopaminergic Neurons during Treadmill Training in 6-OHDA Rat Model of Parkinson’s Disease
by: Zih-Yi Hei, et al.
Published: (2012)

The Neuroprotective Potential of Subthalamic Nucleus Deep Brain Stimulation in the 6-OHDA Rodent Model of Parkinson’s Disease
by: Spieles-Engemann, Anne L.
Published: (2011)

The mechanism of trichloroethylene neurotoxicity and its relation to Parkinsonism
by: Keane, Paul
Published: (2013)

Astrocytic Expression of GSTA4 Is Associated to Dopaminergic Neuroprotection in a Rat 6-OHDA Model of Parkinson’s Disease
by: Michael Jewett, et al.
Published: (2017-06-01)

Propolis as A Potential Disease-Modifying Strategy in Parkinson’s Disease: Cardioprotective and Neuroprotective Effects in the 6-OHDA Rat Model
by: Valeria C. Gonçalves, et al.
Published: (2020-05-01)

Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson’s Disease
by: Carla Ferreira, et al.
Published: (2020-06-01)

Neuroprotective Effect of Optimized Yinxieling Formula in 6-OHDA-Induced Chronic Model of Parkinson’s Disease through the Inflammation Pathway
by: Renrong Wei, et al.
Published: (2019-01-01)

Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity
by: Elisabetta Polazzi, et al.
Published: (2012-05-01)

Neuroprotective effects of carnosic acid in 6-OHDA-treated models
by: Chia-Wen Tsai, et al.
Published: (2013)

The neuroprotective role of osteopontin in in-vitro and in-vivo models of Parkinson's disease
by: Ailane, Sara
Published: (2012)

Neuroprotective effects of metabotropic glutamate receptor ligands in a rodent 6-hydroxydopamine model of Parkinson's disease
by: Vernon, Anthony Christopher
Published: (2007)

Impact of Aging on the 6-OHDA-Induced Rat Model of Parkinson’s Disease
by: Sandra Barata-Antunes, et al.
Published: (2020-05-01)

Fucoxanthin Prevents 6-OHDA-Induced Neurotoxicity by Targeting Keap1
by: Wei Wu, et al.
Published: (2021-01-01)

Pentoxifylline Neuroprotective Effects Are Possibly Related to Its Anti-Inflammatory and TNF-Alpha Inhibitory Properties, in the 6-OHDA Model of Parkinson’s Disease
by: Kelly Rose Tavares Neves, et al.
Published: (2015-01-01)

EGCG Protects against 6-OHDA-Induced Neurotoxicity in a Cell Culture Model
by: Dan Chen, et al.
Published: (2015-01-01)

Palmitate and Stearate are Increased in the Plasma in a 6-OHDA Model of Parkinson’s Disease
by: Anuri Shah, et al.
Published: (2019-02-01)

Early transcranial direct current stimulation treatment exerts neuroprotective effects on 6-OHDA-induced Parkinsonism in rats
by: Xiao-Jun Feng, et al.
Published: (2020-05-01)

Neuroprotective potential of superparamagnetic iron oxide nanoparticles (IONPs) along with exposure to Electro-Magnetic Field in 6-OHDA rat model of Parkinson’s disease
by: Samrat Bose, et al.
Published: (2015-03-01)

An evaluation of the potentially neuroprotective properties of cannabinoids in a cell culture model of Parkinson's disease
by: Zeissler, Marie-Louise
Published: (2013)

Histone deacetylase inhibitors as novel neuroprotective agents in in vitro and in vivo models of Parkinson's disease
by: Page, Cecilia
Published: (2014)

Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons
by: Wang Feifei, et al.
Published: (2008-08-01)

Glucose Homeostasis Is Not Affected in a Murine Model of Parkinson’s Disease Induced by 6-OHDA
by: Felipe Azevedo Gomes, et al.
Published: (2019-01-01)

Neuroprotective Effect of Bergamot Juice in 6-OHDA-Induced SH-SY5Y Cell Death, an <i>In Vitro</i> Model of Parkinson’s Disease
by: Nadia Ferlazzo, et al.
Published: (2020-04-01)

Acylated Ghrelin is Protective Against 6-OHDA-induced Neurotoxicity by Regulating Autophagic Flux
by: Xin He, et al.
Published: (2021-01-01)

Combination Treatment of Icariin and L-DOPA Against 6-OHDA-Lesioned Dopamine Neurotoxicity
by: Di-Sheng Lu, et al.
Published: (2018-05-01)

Identification of bilateral changes in TID1 expression in the 6-OHDA rat model of Parkinson's disease.
by: Juliane Proft, et al.
Published: (2011-01-01)

Cell fate analysis of embryonic ventral mesencephalic grafts in the 6-OHDA model of Parkinson's disease.
by: Sonya Carvalho Neto, et al.
Published: (2012-01-01)

Intrastriatal Grafting of Chromospheres: Survival and Functional Effects in the 6-OHDA Rat Model of Parkinson's Disease.
by: Alejandra Boronat-García, et al.
Published: (2016-01-01)